| Bioactivity | LL-37 FK-13 TFA is the TFA salt form of LL-37 FK-13 (HY-P4836). LL-37 FK-13 TFA is an antimicrobial agent, that inhibits Trichomonas vaginalis. LL-37 FK-13 TFA exhibits minimal hemolytic effects on human erythrocytes and low cytotoxicity to human fibroblasts[1]. |
| Sequence | Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg |
| Shortening | FKRIVQRIKDFLR |
| Formula | C80H135N25O17.xC2HF3O2 |
| Molar Mass | 1719.09 (free acid) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ramírez-Ledesma MG, et al., The antimicrobial peptides LL-37, KR-20, FK-13 and KR-12 inhibit the growth of a sensitive and a metronidazole-resistant strain of Trichomonas vaginalis. Parasitol Res. 2022 Dec;121(12):3503-3512. |
LL-37 FK-13 TFA
CAS: F: C80H135N25O17.xC2HF3O2 W: 1719.09 (free acid)
LL-37 FK-13 TFA is the TFA salt form of LL-37 FK-13 (HY-P4836). LL-37 FK-13 TFA is an antimicrobial agent, that inhibits
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.